J C Roujeau

Summary

Country: France

Publications

  1. ncbi [Notoriety of the French dermatology: analysis through dermatological publications]
    C Longvert
    Service de Dermatologie, Hopital Henri Mondor, 94010 Creteil Cedex, France
    Ann Dermatol Venereol 129:1257-60. 2002
  2. ncbi [Epidermal necrolysis: mechanisms of keratinocyte apoptosis]
    Jean Claude Roujeau
    Service de Dermatologie et Inserm U 659, Hopital Henri Mondor, Universite Paris XII, Faculte de Medecine, 8, rue du Général Sarrail, 94010 Creteil Cedex, France
    Med Sci (Paris) 22:188-91. 2006
  3. ncbi [Dermatomyositis: dermatologic approach]
    J C Roujeau
    Service de Dermatologie, Hopital Henri Mondor, 5, Avenue du Marechal de Lattre de Tassigny, 94000 Creteil, France
    Rev Med Interne 25:13-4. 2004
  4. ncbi Clinical heterogeneity of drug hypersensitivity
    Jean Claude Roujeau
    Service de Dermatologie, Hopital Henri Mondor, Universite Paris XII, 94010 Creteil, France
    Toxicology 209:123-9. 2005
  5. ncbi Immune mechanisms in drug allergy
    Jean Claude Roujeau
    UniversitéParis XII, Department of Dermatology and Inserm U 659, Hopital Henri Mondor, Creteil, France
    Allergol Int 55:27-33. 2006
  6. ncbi Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study
    Jean Claude Roujeau
    Service de Dermatologie, Hopital Henri Mondor, Creteil, France
    Dermatology 209:301-7. 2004
  7. ncbi [Blistering drug reactions]
    J C Roujeau
    Service de dermatologie Hôpital Henri Mondor, Creteil
    Rev Prat 50:1320-3. 2000
  8. doi The value of BP230 enzyme-linked immunosorbent assay in the diagnosis and immunological follow-up of bullous pemphigoid
    L Le Saché-de Peufeilhoux
    Department of Dermatology, Groupe hospitalier Mondor, Creteil, France
    Dermatology 224:154-9. 2012
  9. doi Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study
    N Ortonne
    Departement de Pathologie, Assistance Publique Hopitaux de Paris AP HP, Hopital Henri Mondor, 94010, Creteil Cedex, France
    Br J Dermatol 173:50-8. 2015
  10. doi Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms
    J Chanal
    Department of Dermatology, Assistance Publique Hopitaux de Paris APHP, Groupe Hospitalier Henri Mondor, 51 Avenue du Marechal de Lattre de Tassigny, 94010, Creteil, France
    Br J Dermatol 169:1041-8. 2013

Detail Information

Publications66

  1. ncbi [Notoriety of the French dermatology: analysis through dermatological publications]
    C Longvert
    Service de Dermatologie, Hopital Henri Mondor, 94010 Creteil Cedex, France
    Ann Dermatol Venereol 129:1257-60. 2002
    ..The aim of this study was to evaluate the publications of French dermatologists in medical journals...
  2. ncbi [Epidermal necrolysis: mechanisms of keratinocyte apoptosis]
    Jean Claude Roujeau
    Service de Dermatologie et Inserm U 659, Hopital Henri Mondor, Universite Paris XII, Faculte de Medecine, 8, rue du Général Sarrail, 94010 Creteil Cedex, France
    Med Sci (Paris) 22:188-91. 2006
    ....
  3. ncbi [Dermatomyositis: dermatologic approach]
    J C Roujeau
    Service de Dermatologie, Hopital Henri Mondor, 5, Avenue du Marechal de Lattre de Tassigny, 94000 Creteil, France
    Rev Med Interne 25:13-4. 2004
  4. ncbi Clinical heterogeneity of drug hypersensitivity
    Jean Claude Roujeau
    Service de Dermatologie, Hopital Henri Mondor, Universite Paris XII, 94010 Creteil, France
    Toxicology 209:123-9. 2005
    ..For example, memory cytotoxic T-Cells are key effectors in both localized blisters of bFDE and in extensive blisters of epidermal necrolysis...
  5. ncbi Immune mechanisms in drug allergy
    Jean Claude Roujeau
    UniversitéParis XII, Department of Dermatology and Inserm U 659, Hopital Henri Mondor, Creteil, France
    Allergol Int 55:27-33. 2006
    ..Most drug eruptions appear to result from T-cell mediated delayed hypersensitivity. The secondary activation of different cascades of cytokines, may contribute to the heterogeneity of clinical presentations...
  6. ncbi Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study
    Jean Claude Roujeau
    Service de Dermatologie, Hopital Henri Mondor, Creteil, France
    Dermatology 209:301-7. 2004
    ..To assess the role of foot dermatomycosis (tinea pedis and onychomycosis) and other candidate risk factors in the development of acute bacterial cellulitis of the leg...
  7. ncbi [Blistering drug reactions]
    J C Roujeau
    Service de dermatologie Hôpital Henri Mondor, Creteil
    Rev Prat 50:1320-3. 2000
    ..This paper will review the clinical and histological presentation, drug causes, and prognosis of blistering drug eruptions, with special focus on the most severe: Stevens-Johnson syndrome and Toxic epidermal necrolysis...
  8. doi The value of BP230 enzyme-linked immunosorbent assay in the diagnosis and immunological follow-up of bullous pemphigoid
    L Le Saché-de Peufeilhoux
    Department of Dermatology, Groupe hospitalier Mondor, Creteil, France
    Dermatology 224:154-9. 2012
    ..The value of 230-kDa bullous pemphigoid antibody (BP230) enzyme-linked immunosorbent assay (ELISA) for the diagnosis of bullous pemphigoid (BP) was investigated, but in the immunological follow-up of the disease remains unknown...
  9. doi Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study
    N Ortonne
    Departement de Pathologie, Assistance Publique Hopitaux de Paris AP HP, Hopital Henri Mondor, 94010, Creteil Cedex, France
    Br J Dermatol 173:50-8. 2015
    ..The histopathological features of drug rash with eosinophilia and systemic symptoms (DRESS) syndrome remain poorly characterized...
  10. doi Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms
    J Chanal
    Department of Dermatology, Assistance Publique Hopitaux de Paris APHP, Groupe Hospitalier Henri Mondor, 51 Avenue du Marechal de Lattre de Tassigny, 94010, Creteil, France
    Br J Dermatol 169:1041-8. 2013
    ..It is usually spontaneous and drug induced...
  11. doi [Auto-immune thyroiditis and drug reaction with eosinophilia and systemic symptoms (DRESS) associated with HHV-6 viral reactivation]
    E Funck-Brentano
    Service de Dermatologie, Hopital Henri Mondor, Universite Paris XII, centre de référence des maladies bulleuses immunologiques et toxiques, 51, Avenue du Marechal de Lattre de Tassigny, 94010 Creteil, France
    Ann Dermatol Venereol 138:580-5. 2011
    ..Its physiopathology includes immunological disorders associated with human herpes virus (HHV) reactivation. We report two cases of auto-immune thyroiditis occurring in the context of DRESS syndrome associated with HHV-6 reactivation...
  12. ncbi Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
    J C Roujeau
    Department of Dermatology, Universite Paris XII, Creteil, France
    N Engl J Med 333:1600-7. 1995
    ..Toxic epidermal necrolysis and Stevens-Johnson syndrome are rare, life-threatening, drug-induced cutaneous reactions. We conducted a case-control study to quantify the risks associated with the use of specific drugs...
  13. doi Stevens-Johnson syndrome and toxic epidermal necrolysis: follow-up of pulmonary function after remission
    T A Duong
    Service de Dermatologie, Assistance Publique Hopitaux de Paris, Hôpitaux Universitaires Henri Mondor, 51 Ave du Marechal de Lattre de Tassigny, 94010, Creteil Cedex, France Centre de Référence de Dermatoses Bulleuses Toxiques, Creteil, France
    Br J Dermatol 172:400-5. 2015
    ..Acute-stage specific bronchial epithelial detachment has been described in 27% of patients with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)...
  14. ncbi Poor agreement between self-reported and dermatologists' diagnoses for five common dermatoses
    M Jagou
    Department of Dermatology, University of Paris 12, Hopital Henri Mondor, AP HP, 94010 Creteil, France
    Br J Dermatol 155:1006-12. 2006
    ..As several recent studies have mentioned that self-reported diagnosis either underestimates or overestimates disease prevalence, the validity of such data is questionable...
  15. ncbi [Medical activity in a emergency outpatient department dermatology]
    D Murr
    Service de Dermatologie, Hopital Henri Mondor, 51, Avenue du Marechal de Lattre de Tassigny, 94010 Creteil
    Ann Dermatol Venereol 130:167-70. 2003
    ..The aim of this study was to characterize the medical activity of a dermatology emergency room and to compare it with 1) outpatients, scheduled visits to the same department and 2) visits to community dermatologists in private practice...
  16. doi Psoriasis in France and associated risk factors: results of a case-control study based on a large community survey
    P Wolkenstein
    Department of Dermatology, Albert Chenevier Henri Mondor, Faculty of Medicine, Paris 12 University, Creteil, France
    Dermatology 218:103-9. 2009
    ..Risk factors for psoriasis have been identified...
  17. doi [Cutaneous infections in bullous pemphigoid patients treated with topical corticosteroids]
    Z Boughrara
    Service de Dermatologie, CHU Henri Mondor, 51, Avenue du Marechal de Lattre de Tassigny, 94000 Creteil, France
    Ann Dermatol Venereol 137:345-51. 2010
    ....
  18. doi Management of bullous pemphigoid with topical steroids in the clinical practice of a single center: outcome at 6 and 12 months
    S Ingen-Housz-Oro
    Service de Dermatologie, Université Paris Est Créteil Val de Marne, Creteil, France
    Dermatology 222:176-9. 2011
    ..The efficacy of topical steroids in bullous pemphigoid (BP) was assessed by prospective therapeutic trials. Systemic corticosteroids and immunosuppressant agents are indicated in situations of failure or relapses...
  19. ncbi Evaluation of the potential role of cytokines in toxic epidermal necrolysis
    Amal Nassif
    Inserm U 448, Hopital Henri Mondor, Universite Paris XII, Creteil, France
    J Invest Dermatol 123:850-5. 2004
    ..We propose the hypothesis that the production of Fas-L, TNF-alpha, and IL-10 by keratinocytes could be a defense mechanism against CTL rather than a way of propagating apoptosis among epidermal cells...
  20. doi Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis
    L Valeyrie-Allanore
    Department of Dermatology, Reference Centre for Toxic and Autoimmune Blistering Diseases, Universite Paris XII, F 94010 Cre teil, France
    Br J Dermatol 163:847-53. 2010
    ..The mean ± SD hospital stay was 16.2 +/- 9.1 days.Conclusions Both the death rate and the progression of detachment seemed lower than expected, suggesting a possible usefulness of ciclosporin in SJS and TEN that needs to be confirmed...
  21. ncbi [Drug hypersensitivity syndrome: DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms)]
    E Begon
    Service de Dermatologie, Hopital Henri Mondor, Universite Paris XII, 51, Avenue du Marechal de Lattre de Tassigny, 94010 Creteil Cedex
    Ann Dermatol Venereol 131:293-7. 2004
  22. ncbi [Bullous pemphigoid in young patients: a retrospective study of 74 cases]
    E Bourdon-Lanoy
    Service de Dermatologie, Hopital Henri Mondor, 94010 Creteil, France
    Ann Dermatol Venereol 132:115-22. 2005
    ..Bullous pemphigoid usually affects elderly people. Only a few isolated cases among people younger than 65 years have been reported...
  23. doi [Severe tularaemia mimicking glandular tuberculosis during adalimumab therapy]
    M P Konstantinou
    Service de Dermatologie, Hopital Henri Mondor, AP HP, Universite Paris XII, 94010 Creteil Cedex, France
    Ann Dermatol Venereol 136:718-22. 2009
    ..We report a case of tularaemia in its ulceroglandular form occurring during methotrexate and adalimumab treatment (Humira) for rheumatoid arthritis...
  24. ncbi Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus
    P Saiag
    Departement de Dermatologie, Universite Paris XII, Hopital Henri Mondor, France
    J Am Acad Dermatol 26:567-74. 1992
    ..Although patients infected with the human immunodeficiency virus (HIV) are predisposed to cutaneous adverse drug reactions, only a few cases of toxic epidermal necrolysis (TEN) have been reported in this setting...
  25. ncbi Chilblains and Raynaud phenomenon are usually not a sign of hereditary protein C and S deficiencies
    H Benchikhi
    Department of Dermatology, Henri Mondor Hospital, Creteil, France
    Acta Derm Venereol 78:351-2. 1998
    ..No difference was found in the prevalence of acral manifestations between patients and controls. This study suggests that protein C and S deficiencies are not risk factors for cold-induced acral manifestations...
  26. ncbi Possible relation of Tunisian pemphigus with traditional cosmetics: a multicenter case-control study
    Sylvie Bastuji-Garin
    Department of Public Health, Hôpital Henri Mondor AP HP, Universite Paris XII, Creteil, France
    Am J Epidemiol 155:249-56. 2002
    ..Traditional cosmetics widely used by Tunisian women could play a major role in excess of cases of pemphigus...
  27. doi Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis
    S Lipowicz
    Department of Dermatology, Hopital Henri Mondor, Université Paris Est Créteil, Creteil, France
    Br J Dermatol 168:726-32. 2013
    ..Generalized bullous fixed drug eruption (GBFDE) is a rare cutaneous adverse reaction to drugs, and may resemble Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN), but is usually considered less severe...
  28. ncbi [Severe necrotic and haemorrhagic edema of the upper limbs revealing remitting seronegative symmetrical synovitis with pitting edema]
    S Guegan
    Service de Dermatologie, Hopital Henri Mondor, AP HP, Universite Paris XII, AP HP, 94010 Creteil Cedex
    Ann Dermatol Venereol 133:795-8. 2006
    ..We report a case of RS3PE syndrome associated with unusually severe cutaneous necrotic and haemorrhagic lesions, and revealing malignant monoclonal IgM proliferation...
  29. ncbi [Immunological mechanisms of cutaneous adverse drug reactions]
    E Poszepczynska-Guigne
    Service de Dermatologie, Hopital Henri Mondor, 51, Avenue du Marechal de Lattre de Tassigny, 94010 Creteil, France
    Ann Dermatol Venereol 132:177-83. 2005
  30. doi Poor relevance of a lymphocyte proliferation assay in lamotrigine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis
    Y H Tang
    INSERM U 841, Université Paris Est Créteil, Creteil, France
    Clin Exp Allergy 42:248-54. 2012
    ..Prior use of 'lymphocyte transformation test' (LTT) in Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) provided conflicting results, possibly dependent on sampling dates (acute vs. late)...
  31. ncbi Physiopathology and treatment of severe drug eruptions
    N Bachot
    Service de Dermatologie, , , , France
    Curr Opin Allergy Clin Immunol 1:293-8. 2001
    ..These findings provided the rationale for using new therapeutic approaches, which will be discussed...
  32. doi [Factors associated with delayed diagnosis of bullous pemphigoid]
    S Ingen-Housz-Oro
    Service de Dermatologie, CHU Henri Mondor, 51, Avenue du Marechal de Lattre de Tassigny, 94000 Creteil, France
    Ann Dermatol Venereol 136:696-701. 2009
    ..The first signs of the disease comprise non-specific lesions. We conducted a retrospective study of two large series of cases of BP to identify parameters related to patients or to the disease affecting time to diagnosis (TD)...
  33. ncbi Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome
    G Choquet-Kastylevsky
    Department of Dermatology, Hopital Henri Mondor, Universite Paris XII, Creteil, France
    Br J Dermatol 139:1026-32. 1998
    ....
  34. ncbi Intravenous immunoglobulins in the treatment of severe drug eruptions
    Nicolas Bachot
    Service of Dermatologie, Hospital Henri Mondor, Universite Paris XII, Creteil, France
    Curr Opin Allergy Clin Immunol 3:269-74. 2003
    ..To present and discuss the rationale for using high-dose intravenous human immunoglobulins in the treatment of severe drug eruptions and the clinical results of recently published series...
  35. ncbi Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells
    Amal Nassif
    INSERM U448, Hopital Henri Mondor, Universite Paris XII, F 94010 Creteil, France
    J Allergy Clin Immunol 114:1209-15. 2004
    ..We previously found drug-specific cytotoxic CD8 T lymphocytes in the blisters of a single patient...
  36. ncbi Differential diagnosis of severe cutaneous drug eruptions
    Nicolas Bachot
    Department of Dermatology, Hopital Henri Mondor, Universite Paris XII, Creteil, France
    Am J Clin Dermatol 4:561-72. 2003
    ..Alternatively, a delay in starting a specific treatment for a disease misdiagnosed as a drug eruption could be deleterious...
  37. pmc Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors
    L Le Cleach
    Department of Dermatology, INSERM U448, Hopital Henri Mondor, Creteil, France
    Clin Exp Immunol 119:225-30. 2000
    ..Functionally, we determined that blister T lymphocytes had a cytotoxic T lymphocyte (CTL)- and NK-like cytotoxicity. The role of this cytotoxic lymphocyte population present at the site of lesions during TEN remains to be understood...
  38. ncbi [Cutaneous drug reactions: pharmacogenetic news]
    V Buffard
    Service de Dermatologie, Hopital Henri Mondor, Creteil, France
    Arch Pediatr 11:489-92. 2004
    ..Certain MHC phenotypes are linked to a higher risk of toxidermy, such as in abacavir hypersensitivity or fixed drug eruption. Indeed, severe drug eruptions seem to be linked to a specific immune response controlled by T lymphocytes...
  39. doi [Two cases of psoas abscesses caused by group A beta-haemolytic streptococcal infection with a cutaneous portal of entry]
    E Routier
    Service de Dermatologie, Hopital Henri Mondor, AP HP, 94010 Creteil, France
    Ann Dermatol Venereol 137:369-72. 2010
    ..We report two cases of psoas abscesses caused by group A beta-haemolytic streptococcal infection having a cutaneous portal of entry...
  40. ncbi [Toxic epidermal necrolysis and Stevens-Johnson syndrome]
    Jean Claude Roujeau
    centre de référence maladies rares, dermatoses bulleuses immunologiques et toxiques, Service de Dermatologie, Hopital Henri Mondor, INSERM U659, Universite Paris XII, 94010 Creteil
    Rev Prat 57:1165-70. 2007
    ..A dozen "high risk" medications account for 50% of cases. Symptomatic management in specialized units is urgent. The mortality rate is high (20-25%) and about one half of survivors will have sequelae, especially on the eyes...
  41. ncbi Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression
    Nicolas Bachot
    Department of Dermatology, Hopital Henri Mondor, Creteil, France
    Arch Dermatol 139:33-6. 2003
    ....
  42. ncbi Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome
    Pierre Dominique Ghislain
    Service de Dermatologie, Hopital Henri Mondor, Universite Paris XII, Creteil, France
    Dermatol Online J 8:5. 2002
    ..Sunblocks are recommended. Testing for glycemia must be done. Avoidance of the responsible drug and chemically related compounds is essential for the patient and first-degree relatives...
  43. ncbi Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis
    Sarah Guegan
    Department of Dermatology, Henri Mondor Hospital AP HP, University Paris XII, Creteil, France
    J Invest Dermatol 126:272-6. 2006
    ..The SCORTEN performance during the first 5 days of hospitalization was excellent, and at its best on day 3. We recommend to compute again the SCORTEN on day 3. The admission delay did not influence prognosis or SCORTEN...
  44. ncbi Severe adverse drug reactions due to pseudoephedrine from over-the-counter medications
    H Assier-Bonnet
    Service de Dermatologie, Hopital Henri Mondor, 94010 Creteil, Hopital Saint Louis, Paris, France
    Contact Dermatitis 47:165-82. 2002
  45. ncbi [Calciphylaxis: a rare differential diagnosis of systemic vasculitis]
    M Khellaf
    Service de Medecine Interne, CHU Henri Mondor, 51, avenue de Lattre de Tassigny, 94010 Creteil, France
    Rev Med Interne 27:240-3. 2006
    ..Calciphylaxis is a rare phenomenon of medium- and small-vessel calcifications leading to cutaneous necrosis mimicking vasculitis...
  46. ncbi Treatment of bullous pemphigoid and pemphigus. The French experience, 2009 update
    J C Roujeau
    Ile de France Reference Center on toxic and Auto Immune Blistering Diseases, Henri Mondor Hospital, Paris XII University, Creteil, France
    G Ital Dermatol Venereol 144:333-8. 2009
    ..Because of concerns on long-term safety, multicenter trials of these ''biological'' treatments should be undertaken urgently...
  47. ncbi Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis
    Amal Nassif
    INSERM U 448 Department of Dermatology, Hôpital H Mondor, Universite Paris XII, Creteil, France
    J Invest Dermatol 118:728-33. 2002
    ..These results challenge several current concepts and could support new therapeutic approaches...
  48. ncbi Drug-induced skin, nail and hair disorders
    Laurence Valeyrie-Allanore
    University of Paris XII, Creteil, France
    Drug Saf 30:1011-30. 2007
    ....
  49. ncbi Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV Ig): clinical experience to date
    Ousmane Faye
    Department of Dermatology, Hopital Henri Mondor, Universite Paris XII, Creteil, France
    Drugs 65:2085-90. 2005
    ..We conclude that, in the absence of further studies, IV Ig cannot yet be considered the standard of care for SJS or TEN...
  50. doi Minocycline-induced DRESS: evidence for accumulation of the culprit drug
    Eve Maubec
    Department of Dermatology, Hopital Henri Mondor, Assistance Publique Hopitaux de Paris, Creteil, France
    Dermatology 216:200-4. 2008
    ..Minocycline-induced drug rash with eosinophilia and systemic symptoms (DRESS) may have a prolonged course, especially in African and African-American patients...
  51. ncbi Acute bacterial skin infections and cellulitis
    Marion Gabillot-Carré
    Hopital Henri Mondor, Creteil, France
    Curr Opin Infect Dis 20:118-23. 2007
    ..We separate acute nonnecrotizing infections of the hypodermis (erysipelas), forms with abscesses or exudates and necrotizing fasciitis. These three types actually differ in risk factors, bacteriology, treatment and prognosis...
  52. ncbi Severe sialadenitis: a new complication of drug reaction with eosinophilia and systemic symptoms
    Sophia Abecassis
    Departments of Dermatology, Hopital Henri Mondor, Creteil, France
    J Am Acad Dermatol 51:827-30. 2004
    ..Drug cutaneous reaction and isolated cases of parotitis induced by terbinafine have been reported...
  53. ncbi EMPACT syndrome
    Maja Mockenhaupt
    J Dtsch Dermatol Ges 3:569-70; author reply 570. 2005
  54. ncbi Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS
    Muriel Eliaszewicz
    Department of Infectious Diseases, Hôpital de l Institut Pasteur, Paris, France
    J Am Acad Dermatol 47:40-6. 2002
    ..Persons with HIV infection have increased rates of drug eruptions...
  55. doi A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
    Christine Lonjou
    INSERM, U563 Paul Sabatier University III, Toulouse, France
    Pharmacogenet Genomics 18:99-107. 2008
    ..Recently, a strong association between carbamazepine and allopurinol induced SJS or TEN has been described with respectively, HLA-B*1502 and HLA-B*5801 in a Han Chinese population from Taiwan and other Asian countries...
  56. ncbi Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study
    Ariane Auquier-Dunant
    Department of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France
    Arch Dermatol 138:1019-24. 2002
    ..It was proposed that Stevens-Johnson syndrome and toxic epidermal necrolysis differed from erythema multiforme majus by the pattern and localization of skin lesions...
  57. ncbi Denominations and classification of severe cutaneous adverse reactions to drugs: splitters versus mergers
    Laurence Valeyrie-Allanore
    Eur J Dermatol 17:359-60. 2007
  58. ncbi Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel
    Sima Halevy
    Department of Dermatology, Soroka University Medical Center, Ben Gurion University of the Negev, Beer Sheva, Israel
    J Am Acad Dermatol 58:25-32. 2008
    ..Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare severe cutaneous adverse reactions...
  59. ncbi Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study
    Maja Mockenhaupt
    Dokumentationszentrum schwerer Hautreaktionen, Department of Dermatology, University Medical Center, Freiburg, Germany
    J Invest Dermatol 128:35-44. 2008
    ..The use of such drugs as first-line therapies should be considered carefully, especially when safer alternative treatments exist. A number of widely used drugs did not show any risk for SJS and TEN...
  60. ncbi Cell-mediated immunologic mechanism and severity of TEN
    Ousmane Faye
    Arch Dermatol 141:775-6. 2005
  61. ncbi Terbinafine-induced subacute cutaneous lupus erythematosus
    David Farhi
    Department of Dermatology 1, Saint Louis Hospital, Paris, France
    Dermatology 212:59-65. 2006
    ..Nearly 10% of lupus erythematosus (LE) are drug induced. More than 60 different drugs are involved in iatrogenic LE. We report herein 3 cases of terbinafine-induced LE...
  62. ncbi French people and skin diseases: results of a survey using a representative sample
    Pierre Wolkenstein
    Department of Dermatology and Public Health, University Paris XII, Hôpital Henri Mondor AP HP, Creteil, France
    Arch Dermatol 139:1614-9; discussion 1619. 2003
    ..To evaluate, from the patients' viewpoint, the prevalence, management, and impact of main dermatologic disorders in France...
  63. ncbi Pemphigus vulgaris: a case-based update
    Nadia Ben Lagha
    Faculty of Oral Surgery, Department of Odontology, Hopital Charles Foix, Ivry sur Seine, France
    J Can Dent Assoc 71:667-72. 2005
    ..The article also reviews the current literature on diagnosis and treatment of the condition...
  64. ncbi A single cycle of rituximab for the treatment of severe pemphigus
    Pascal Joly
    Rouen University Hospital, Rouen, France
    N Engl J Med 357:545-52. 2007
    ..The aim of this study was to assess the efficacy of a single cycle of rituximab in severe types of pemphigus...
  65. ncbi Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples
    Osvaldo Correia
    Department of Dermatology, Instituto Português Oncologia, 4200 Porto, Portugal
    Arch Dermatol 138:29-32. 2002
    ....
  66. ncbi Association analysis of drug metabolizing enzyme gene polymorphisms in AIDS patients with cutaneous reactions to sulfonamides
    Pierre Wolkenstein
    J Invest Dermatol 125:1080-2. 2005